Comerica Securities’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.25M | Sell |
12,094
-912
| -7% | -$228K | 0.27% | 93 |
|
|
2023
Q2 | $2.89M | Buy |
13,006
+940
| +8% | +$218K | 0.2% | 114 |
|
|
2023
Q1 | $2.92M | Buy |
12,066
+990
| +9% | +$243K | 0.21% | 114 |
|
|
2022
Q4 | $2.91M | Sell |
11,076
-501
| -4% | -$134K | 0.21% | 116 |
|
|
2022
Q3 | $2.61M | Buy |
11,577
+429
| +4% | +$104K | 0.21% | 113 |
|
|
2022
Q2 | $2.71M | Sell |
11,148
-548
| -5% | -$134K | 0.21% | 118 |
|
|
2022
Q1 | $2.83M | Buy |
11,696
+323
| +3% | +$74.2K | 0.19% | 125 |
|
|
2021
Q4 | $2.56M | Sell |
11,373
-515
| -4% | -$109K | 0.16% | 134 |
|
|
2021
Q3 | $2.53M | Sell |
11,888
-3,275
| -22% | -$754K | 0.18% | 132 |
|
|
2021
Q2 | $3.7M | Sell |
15,163
-1,179
| -7% | -$290K | 0.28% | 93 |
|
|
2021
Q1 | $4.07M | Sell |
16,342
-880
| -5% | -$210K | 0.31% | 81 |
|
|
2020
Q4 | $3.96M | Buy |
17,222
+659
| +4% | +$152K | 0.32% | 77 |
|
|
2020
Q3 | $4.21M | Buy |
16,563
+224
| +1% | +$55.5K | 0.38% | 72 |
|
|
2020
Q2 | $3.85M | Buy |
16,339
+1,327
| +9% | +$303K | 0.36% | 72 |
|
|
2020
Q1 | $3.04M | Buy |
15,012
+4,067
| +37% | +$888K | 0.34% | 76 |
|
|
2019
Q4 | $2.64M | Buy |
10,945
+380
| +4% | +$83.8K | 0.25% | 98 |
|
|
2019
Q3 | $2.04M | Buy |
10,565
+711
| +7% | +$136K | 0.21% | 115 |
|
|
2019
Q2 | $1.82M | Sell |
9,854
-7,519
| -43% | -$1.35M | 0.19% | 120 |
|
|
2019
Q1 | $3.3M | Buy |
17,373
+1,578
| +10% | +$301K | 0.37% | 73 |
|
|
2018
Q4 | $3.08M | Buy |
15,795
+362
| +2% | +$70.6K | 0.41% | 63 |
|
|
2018
Q3 | $3.2M | Sell |
15,433
-24
| -0.2% | -$4.73K | 0.38% | 72 |
|
|
2018
Q2 | $2.85M | Buy |
15,457
+36
| +0.2% | +$6.37K | 0.35% | 83 |
|
|
2018
Q1 | $2.63M | Buy |
15,421
+1,161
| +8% | +$213K | 0.33% | 91 |
|
|
2017
Q4 | $2.48M | Buy |
14,260
+1,070
| +8% | +$189K | 0.31% | 91 |
|
|
2017
Q3 | $2.46M | Sell |
13,190
-143
| -1% | -$25.3K | 0.34% | 84 |
|
|
2017
Q2 | $2.3M | Buy |
13,333
+725
| +6% | +$118K | 0.34% | 89 |
|
|
2017
Q1 | $2.07M | Buy |
+12,608
| New | +$2.09M | 0.33% | 94 |
|
|
2015
Q3 | – | Sell |
-2,581
| Closed | -$396K | – | 191 |
|
|
2015
Q2 | $396K | Buy |
2,581
+617
| +31% | +$98.8K | 0.1% | 216 |
|
|
2015
Q1 | $314K | Sell |
1,964
-163
| -8% | -$25.7K | 0.08% | 233 |
|
|
2014
Q4 | $339K | Sell |
2,127
-325
| -13% | -$50.6K | 0.22% | 89 |
|
|
2014
Q3 | $344K | Buy |
+2,452
| New | +$320K | 0.24% | 101 |
|
Other funds holding AMGN
Comerica Securities's AMGN Position: Q3 2023 in Review
Comerica Securities reduced its Amgen (AMGN) stake by 7% in Q3 2023, selling an estimated $228K and leaving 12,094 shares worth $3.25M. The position accounts for 0.27% of the portfolio, ranked #93.
Comerica Securities first reported a position in AMGN in Q3 2014 and has held it in 31 quarters since. The position peaked at $4.21M in Q3 2020. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Comerica Securities held 12,094 shares of Amgen worth $3.25M as of Q3 2023.
- Comerica Securities sold 912 Amgen shares in Q3 2023, an estimated $228K.
- Amgen made up 0.27% of Comerica Securities's portfolio in Q3 2023, its #93 holding.
- Comerica Securities first reported a position in Amgen in Q3 2014 and has held it in 31 quarters since.
- Comerica Securities's Amgen position peaked at $4.21M in Q3 2020.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.